SALT LAKE CITY — The Utah Department of Commerce's Division of Consumer Protection and the Utah Attorney General's Office have reached a settlement with global pharmaceutical company Sandoz Inc. in a ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
Hims & Hers Health Inc. HIMS-N, one of the largest U.S. telehealth providers, is entering the Canadian market with the acquisition of Montreal-based Livewell on Thursday and expects to ride the wave ...
A significant majority of American voters say they would rather elect a Democrat than a Republican to represent them in Congress in next year’s midterms, according to the latest Marist Poll. The ...
Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C. Michael White, University of Connecticut (THE CONVERSATION) A generic blood ...
FRANKFURT (Reuters) -Novartis' blockbuster heart treatment Entresto saw sales growth stall in the third quarter of the year, dragging the Swiss company's shares lower, as its top-selling drug comes ...
Recently, President Trump signed a “most-favored nation” executive order on drug prices with a claim that it would force pharmaceutical companies to lower U.S. prescription costs to match those abroad ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results